Sign in

Back to Explore

Pharma8k's

Latest news, insights and analysis on Pharma8k's and the regenerative medicine industry

Latest Posts

Edesa Biotech (EDSA) Reports Phase 3 Success for ARDS Drug, $7.2M FY2025 Loss

Teddy V. · 12 Dec 2025

CDT Equity Inc. (CDT) Sells Subsidiary Conduit Pharmaceuticals for $7 Million

Teddy V. · 12 Dec 2025

Century Therapeutics (IPSC) Reports Positive Clinical Data for Three Pipeline Candidates in Autoimmune and Diabetes Programs

Teddy V. · 12 Dec 2025

Contributors

T

Teddy V.

Creator of Pharma8k's